2019 Global Market Outlook – Q3 update: China syndrome
China stimulus, global central bank easing and a China-U.S. trade-war ceasefire could set the scene for a rebound in the global economy later in the year. However, the inversion of the U.S. Treasury yield curve and the downtrend in business confidence indicators keep us cautious at mid-year.
Key market themes
U.S. President Donald Trump's tariff increase on Chinese imports in May triggered the end of this year’s equity market recovery. While the stock market has since rebounded, the lasting impact can be seen in falling long-term government bond yields, the inverted U.S. yield curve, the slowdown in global trade and weak global manufacturing surveys. As a result, it now looks increasingly likely that the U.S. Federal Reserve (the Fed) will cut interest rates in both July and September. A combination of Fed easing, China stimulus and trade compromise could make the recent yield-curve inversion a false signal. We will take the inversion much more seriously if it persists for a couple more months. At mid-year, it’s a worrying indicator that biases us toward caution.
In Europe, the region’s long-anticipated growth rebound remains just that—anticipated. Growth indicators are lacklustre. And persistent low inflation has the European Central Bank pushing rate hikes further into the future. Bond market expectations for inflation in five years’ time have fallen to a record low of 1.2% as of mid-June. We’re not bearish on Europe, but the one-off factors that depressed growth are taking longer to turn around than anticipated. Overall, we see no signs that eurozone equities are either overbought or oversold, while core government bonds look long-term expensive.
The ongoing Brexit uncertainty continues to weigh on the British economy. We think British sterling will remain volatile in the short-term, but a rebound in the currency looks likely if the UK’s new prime minister can secure a deal with Europe, or if a second referendum is called.
The escalation of the China-U.S. trade war has put pressure on growth in the Asia-Pacific region, which suggests there will be further Chinese government stimulus measures that should benefit the region. Although the outlook for Australia remains lacklustre, there have been a number of positive developments that should help the housing market stabilise, including a rate cut by the Reserve Bank of Australia. While we believe the Australian equity market is fully valued, we see slightly attractive valuations in Japan and Emerging Asia.
We believe the Canadian economy is gradually recovering, but we remain neutral on our outlook for domestic equities. We don't see valuations as compelling yet, and our contrarian sentiment indicators remain far from oversold.
- Fading fiscal stimulus is likely to slow the U.S. economy relative to its breakneck pace from 2018. In addition, the Trump administration’s aggressive trade stance with China is exacting a heavy toll on the U.S. and the global economy.
- Midway through 2019, the U.S. manufacturing cycle remains weak. In addition, the global manufacturing cycle has continued to decelerate, and at mid-year is approaching recessionary levels.
- Fiscal easing in the eurozone should provide a decent tailwind, with the European Commission expecting fiscal thrust of 0.4% of GDP (gross domestic product) this year.
- Trade-war uncertainty is depressing businesses’ confidence and international trade. JPMorgan’s tracker of global business capital expenditure is signalling negative business investment spending for the second quarter of 2019, after healthy growth through most of 2018.
- Exports from Asia-Pacific have slowed, while manufacturing activity growth in countries such as South Korea and Taiwan has contracted.
Asset class views
Equities: Broadly neutral to slightly underweight
Our cycle, value and sentiment investment process points to a broadly neutral to slightly underweight view on global equities. We have an underweight preference for U.S. equities, driven by expensive valuation and cycle concerns around the trade-war escalation, fading fiscal stimulus and yield-curve inversion. We’re broadly neutral on non-U.S. developed equities. We see valuation in Japan as slightly positive and neutral in Europe. Both should benefit from stimulus in China, which will help bolster export demand.
Fixed income: Universally expensive
We see government bonds as universally expensive, although we believe U.S. Treasuries are closer to fair value than German bunds, Japanese government bonds and UK gilts. High-yield credit is expensive and losing cycle support, which is typical late in the cycle, when profit growth slows and there are concerns about defaults.
Currencies: Preference for Japanese yen
The Japanese yen is our preferred currency as we look toward the third quarter. It’s undervalued and has safe-haven appeal if the trade war escalates. The U.S. dollar could weaken once the Fed eases. The main beneficiaries of this would be emerging market currencies. At this juncture, the euro and British sterling appear undervalued.
Read our complete 2019 Global Market Outlook – Q3 update
Any opinion expressed is that of Russell Investments, is not a statement of fact, is subject to change and does not constitute investment advice.
The information on this website is only intended for use by professional clients, regulated financial advisers and intermediaries who are knowledgeable and experienced in the financial services market and in investment products of this nature. If you are a retail or individual investor then please leave this website immediately and consult your financial adviser.
You should not use this website unless you understand its nature and the extent of your exposure to risk. You should also be satisfied that the website and investments are suitable for your client in light of their circumstances and financial position.
The information contained on this website is for information purposes only and you should not take it as constituting an offer, solicitation, inducement, commitment or invitation to subscribe for or to purchase, sell or hold any interest in any of the investments mentioned herein.
This website is not intended for distribution or use by anyone in any jurisdiction in which such distribution or use would be prohibited. Nothing on this website or in the materials referred to therein constitutes, or is intended to constitute, financial, tax, legal or other advice.
The value of investments, and the income from them, can go down as well as up and you may get back less than the amount invested. Any past performance figures are not necessarily a guide to future performance.
The website may contain forward-looking statements, which are based on a number of assumptions regarding present and future business strategies, which may or may not prove to be correct. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Forward-looking statements are not guarantees of future performance.
Issued by Russell Investments Limited. Company No. 02086230 and Russell Investments Implementation Services Limited Company No. 3049880. Registered in England and Wales with registered office at: Rex House, 10 Regent Street, London SW1Y 4PE. Telephone +44 (0)20 7024 6000. Authorised and regulated by the Financial Conduct Authority, 12 Endeavour Square, London E20 1JN.
All reasonable care has been taken by us to ensure that the information contained on this website is accurate at the time of publication. However, we accept no responsibility for the accuracy, adequacy or completeness of the information and materials contained on this website and expressly disclaim liability for errors or omissions in such information and materials. We and our respective affiliates do not have any obligation to update the information contained in this website and reserve the right to change these terms and conditions at any time, without notice.
We will not regard you or any person who accesses this website as our client in relation to any of the investment products or services detailed therein, unless expressly agreed.